#+TITLE: Laboratory Methods for Quantitative Acylcarnitines in Biological Matrices
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today

* Introduction
- carnitine (\beta{}-hydroxy-\gamma{}-N-trimethylaminobutyric acid) is
  an endogenous quaternary ammonium compound synthesized from lysine
  and methionine
- L-Carnitine has been described as a "conditionally essential"
  nutrient for humans
- exogenous carnitine is required to maintain plasma carnitine
  concentrations in humans of all ages especially:
  - infants (premature and full-term)
  - patients on long-term parenteral nutrition
  - children
- primary function is to shuttle long chain fatty acids to the
  mitochondrial matrix, for \beta-oxidation
- acylcarnitines are markers for FAODs and OAs

#+BEGIN_EXPORT LaTeX
\chemnameinit{}
\chemname{\chemfig{H3C-N^{+}([2]-CH3)([6]-CH3)-CH2-C([2]-H)([6]-OH)-CH_2-C([1]=O)([7]-O^{-})}}{\small Carnitine}
\hspace{3em}
\chemname{\chemfig{H3C-N^{+}([2]-CH3)([6]-CH3)-CH2-C([2]-H)([6]-O-C([0]=O)-{\color{red}R})-CH_2-C([1]=O)([7]-O^{-})}}{\small Acylcarnitine}
%\chemname{\chemfig[][scale=.5]{H3C-N^{+}([2]-CH3)([6]-CH3)-CH2-C([2]-H)([6]-O-C([0]=O)-{\color{red}R})-CH_2-C([2]=O)-O-CH_2-CH_2-CH_2-CH_3}}{\small Acylcarnitine, butyl ester}
#+END_EXPORT

* Diagnostic FIA-MS/MS
** Sample Prep

- acylcarnitines in the sample are esterified as butyl esters with
  butanol-hydrogen chloride
- extraction?
- solvent delivery is via HPLC with no chromatography, called flow
  injection analysis
- 10 \micro{}L of sample extract is injected into a flowing stream
  operating at ~ 0.15 ml/min

#+BEGIN_EXPORT LaTeX
\chemnameinit{}
\definesubmol{x}{-[1,.6]-[7,.6]}
\definesubmol{y}{-[7,.6]-[1,.6]}
\definesubmol{d}{!y!y-[7,.6]{\color{red}COOH}}
\definesubmol{e}{!y!y}
\schemestart
\chemname{\chemfig{-N^{+}([2]-)([6]-)-[1]-[7]([6]-O-([5]=O)!e)-[1]-[7]([7]=O)([1]-O^{-})}}{\small C5-carnitine}
\+
\chemname{\chemfig{HO!x!x}}{\small n-butanol}
\arrow{-U>[][{\small \ce{H2O}}]}
\chemname{\chemfig{-N^{+}([2]-)([6]-)-[1]-[7]([6]-O-([5]=O)!e)-[1]-[7]([6]=O)-[1,.6]O!y!y}}{\small C5-carnitine, butyl ester}
\schemestop

\vspace{2em}

\schemestart
\chemname{\chemfig{-N^{+}([2]-)([6]-)-[1]-[7]([6]-O-([5]=O)!d)-[1]-[7]([7]=O)([1]-O^{-})}}{\small C6DC-carnitine}
\+
\chemname{\chemfig{HO!x!x}}{\small n-butanol}
\arrow{-U>[][{\small \ce{2H2O}}]}
\chemname{\chemfig{-N^{+}([2]-)([6]-)-[1]-[7]([6]-O-([5]=O)!e-[7,.6]O!x!x)-[1]-[7]([6]=O)-[1,.6]O!y!y}}{\small C6DC-carnitine, butyl ester}
\schemestop 
#+END_EXPORT

#+CAPTION[]:Rationale for Derivatization
#+NAME: fig:deriv
#+ATTR_LaTeX: :width 0.9\textwidth
[[file:./ac/figures/ionization.png]]

#+begin_src gnuplot :var data=data-table :file ./ac/figures/outletmethod.pdf
reset
set title "FIA-MS/MS Method"
set key on
set xlabel "min"

set xrange [0:3]

set ylabel "ml/min"
set yrange [0:1.2]

plot data u 1:2 w lp lw 2 t "80% ACN"

#+end_src

#+CAPTION[]: FIA-MS/MS Method
#+NAME: fig:acout
#+ATTR_LaTeX: :width 1.0\textwidth
#+RESULTS:
[[file:./ac/figures/outletmethod.pdf]]

** FIA-MS/MS schematic
#+BEGIN_EXPORT LaTeX
\begin{center}
\begin{tikzpicture}[node distance=7em]
% nodes
\node(ms1)[ms]{MS1: Mass Filter};
\node(cc)[ms, right of=ms1]{Collision cell};
\node(ms2)[ms, right of=cc]{MS2: Mass Filter};
\node(ion)[ms, below of=ms1,yshift=3em]{Ionization};
\node(lc)[msw, below of=ion,yshift=3em]{Injection};
\node(detector)[ms, below of=ms2, yshift=3em]{Detector};
% arrows
\draw[arrow](lc) -- (ion);
\draw[arrow](ion) -- (ms1);
\draw[arrow](ms1) -- (cc);
\draw[arrow](cc) -- (ms2);
\draw[arrow](ms2) -- (detector);
\end{tikzpicture}
\end{center}
#+END_EXPORT

** Inlet table                                                     :noexport:

#+tblname: data-table
| Time |  Flow |  %A | %B |
|------+-------+-----+----|
|    0 |  1.00 | 100 |  0 |
|  0.3 | 0.095 | 100 |  0 |
|  1.2 | 0.100 | 100 |  0 |
| 1.55 | 0.500 | 100 |  0 |
| 1.85 | 0.100 | 100 |  0 |
|  2.5 | 0.100 | 100 |  0 |


#+CAPTION[]:Typical Acylcarnitine Panel
#+NAME: tab:acpanel
| Carbons  | Name                                                    |
|----------+---------------------------------------------------------|
| C2       | acetylcarnitine                                         |
| C3       | propionylcarnitine                                      |
| C4       | butyryl-/isobutyrylcarnitine                            |
| C5:1     | tiglylcarnitine                                         |
| C5       | isovaleryl-/2-methylbutyryl-/pivalylcarnitine           |
| C6       | hexanoylcarnitine                                       |
| C5-OH    | 3-hydroxyisovaleryl-/2-methyl-3-hydroxybutyrylcarnitine |
| C8:1     | octenoylcarnitine                                       |
| C8       | octanoylcarnitine                                       |
| C3-DC    | malonylcarnitine                                        |
| C10:2    | decadienoylcarnitine                                    |
| C10:1    | decenoylcarnitine                                       |
| C10      | decanoylcarnitine                                       |
| C4-DC    | methylmalonyl-/succinylcarnitine                        |
| C5-DC    | glutarylcarnitine                                       |
| C12:1    | dodecenoylcarnitine                                     |
| C12      | dodecanoylcarnitine                                     |
| C6-DC    | adipyl-/methylglutarylcarnitine                         |
| C14:2    | tetradecadienoylcarnitine                               |
| C14:1    | tetradecenoylcarnitine                                  |
| C14      | myristoylcarnitine                                      |
| C8-DC    | suberylcarnitine                                        |
| C14-OH   | 3-hydroxymyristoylcarnitine                             |
| C16:1    | palmitoleylcarnitine                                    |
| C16      | palmitoylcarnitine                                      |
| C10-DC   | sebacylcarnitine                                        |
| C16:1-OH | 3-hydroxypalmitoleylcarnitine                           |
| C16      | 3-hydroxypalmitoylcarnitine                             |
| C18:2    | linoleylcarnitine                                       |
| C18:1    | oleylcarnitine                                          |
| C18      | stearoylcarnitine                                       |
| C18:2-OH | 3-hydroxylinoleylcarnitine                              |
| C18:1-OH | 3-hydroxyoleylcarnitine                                 |
| C18-OH   | 3-hydroxystearoylcarnitine                              |
| C16-DC   | hexadecanedioylcarnitine                                |


** Precursor Ion Scan
- electrospray ionization in positive mode
- butylated acylcarnitines fragment to produce a characteristic ion with mass of 85 Da 
- precursor ion scan is used to identify molecules that fragment to form a 85 m/z molecule

#+BEGIN_EXPORT LaTeX
\chemnameinit{}
\definesubmol{x}{-[1,.6]-[7,.6]}
 \chemname{\chemfig{H_{3}C-N^{+}([2]-CH_3)([6]-CH_{3})-CH_2-C([2]-H)([6]-O-C([0]=O)-{\color{red}R})-CH_2-C([2]=O)-O-CH_2-CH_2-CH_2-CH_3}}{\small acylcarnitine, butyl ester}

\vspace{2.5em}
\chemnameinit{}
 \chemname{\chemfig{H_{3}C-N([1]-CH_3)([7]-CH_3)}}{\small trimethylamine}
\hspace{2em}
\chemname{\chemfig{{\color{red}R}-C([1]=O)([7]-OH)}}{\small carboxylic acid}
\hspace{2em}
 \chemname{\chemfig{H!x!x}}{\small butyl group}
\hspace{2em}
 \chemname{\chemfig{H_{2}C^{+}-HC=CH-C([1]=O)([7]-OH)}}{\small 85 m/z}
#+END_EXPORT


#+CAPTION[]:Precursor Ion Scan
#+NAME: fig:pis
#+ATTR_LaTeX: :width 0.9\textwidth
#+BEGIN_EXPORT LaTeX
\begin{center}
\begin{tikzpicture}
\node[box](ms1)[]{};
\node[label](ms1u)[above=of ms1,yshift=-3em]{MS1};
\node[label](ms1l)[below=of ms1,yshift=3em]{scanning};
\node[box](cc)[right= of ms1]{};
\node[label](ccu)[above=of cc,yshift=-3em]{Collision cell};
\node[label](ccl)[below=of cc,yshift=3em]{fragmentation};
\node[box](ms2)[right= of cc]{};
\node[label](ms2u)[above=of ms2,yshift=-3em]{MS2};
\node[label](ms2l)[below=of ms2,yshift=3em]{85 m/z};
\draw[->](ms1) -- (cc);
\draw[->](cc) -- (ms2);

%ms1
\draw [gray,->, decorate,decoration=snake] (-.8,0.5) -- (.8,0.5);
\draw [gray,->, decorate,decoration=snake] (-.8,0.25) -- (.8,0.25);
\draw [blue, ->, decorate,decoration=snake] (-.8, 0) -- (.8,0);
\draw [gray,->, decorate,decoration=snake] (-.8,-0.25) -- (.8,-0.25);
\draw [gray,->, decorate,decoration=snake] (-.8,-0.5) -- (.8,-0.5);

%cc
\draw [blue,->,decorate,decoration=snake] (2.1, 0) -- (2.4,0);
\fill (2.6,0) circle (0.1); 
\draw [gray,->,decorate,decoration=snake] (2.8, 0) -- (3.8,0.5);
\draw [red, ->,decorate,decoration=snake] (2.8, 0) -- (3.8,0);
\draw [gray,->,decorate,decoration=snake] (2.8, 0) -- (3.8,-0.5);

%ms2
\draw [red,->,decorate,decoration=snake] (5.1, 0) -- (6.8,0);
\end{tikzpicture}
\end{center}
#+END_EXPORT


** Overestimation of Free Carnitine
- butylated acylcarnitines are converted to butylated carnitine in
  n-butanol-3M HCl at 65\degree{}C [fn:johnson]

#+CAPTION[]:Overestimation of Free Carnitine
#+NAME: tab:c0
| Acyl Carnitine | Half-life (min) |
|----------------+-----------------|
| C2             |              31 |
| C10            |             125 |
| C18            |             172 |

- 65\degree{}C for 15 min.  
- NSO uses 60\degree{}C for 20 minutes.
- IMD uses 55\degree{}C for 20 minutes.

- in a sample with low free carnitine and high acetylcarnitine
  - 30% of the acetylcarnitine and smaller amounts of higher
    molecular mass acylcarnitines are converted to carnitine
  - a low carnitine sample could appear to be normal
- "the free carnitine results obtained by this screening method on
  blood spots with high levels of acylcarnitines should therefore be
  used with caution" [fn:johnson]

[fn:johnson] Johnson, D. W. (1999). Inaccurate measurement of free
carnitine by the electrospray tandem mass spectrometry screening
method for blood spots. Journal of Inherited Metabolic Disease, 22(2),
201â€“202. 


* TODO Free and Total Carnitine
- Method?
** Fractional Tubular Re-absorption of Carnitine

#+BEGIN_EXPORT LaTeX
\begin{equation*}
FTR_{carnitine}\% = \left( 1 -  \frac{carnitine_{urine} \cdot creatinine_{plasma}}{carnitine_{plasma} \cdot creatinine_{urine}}\right) \cdot 100
\end{equation*}
#+END_EXPORT

- normally >98%, \Downarrow in CUD

** Free/Total Carnitine

\[
\frac{Free_{carnitine}}{Total_{carnitine}} = \frac{C_0}{\sum_{0}^{18} C_n}
\]

- \Downarrow in CUD, < 5-10% of normal 
